Product NDC: | 66993-175 |
Proprietary Name: | Dorzolamide Hydrochloride |
Non Proprietary Name: | dorzolamide hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; dorzolamide hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66993-175 |
Labeler Name: | Prasco Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020408 |
Marketing Category: | NDA |
Start Marketing Date: | 19941209 |
Package NDC: | 66993-175-20 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (66993-175-20) > 10 mL in 1 BOTTLE, DROPPER |
NDC Code | 66993-175-20 |
Proprietary Name | Dorzolamide Hydrochloride |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (66993-175-20) > 10 mL in 1 BOTTLE, DROPPER |
Product NDC | 66993-175 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dorzolamide hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 19941209 |
Marketing Category Name | NDA |
Labeler Name | Prasco Laboratories |
Substance Name | DORZOLAMIDE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |